High phospho-Stathmin (Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition

From WikiCitingRetracted
Revision as of 07:50, 9 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == High phospho-Stathmin (Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition; E Wik, E Birkeland, J Trovik, HMJ Wernerae; 2013; doi_citing_unknown == Retraction == Retracted: A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus; Misra UK, Dubey D, Kalita J.; 2017-5-01 ; https://doi.org/10.1111/epi.13706 == Citation piece == Note: Open to append information.")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Target Article[edit | edit source]

High phospho-Stathmin (Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition; E Wik, E Birkeland, J Trovik, HMJ Wernerae; 2013; doi_citing_unknown

Retraction[edit | edit source]

Retracted: A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus; Misra UK, Dubey D, Kalita J.; 2017-5-01

https://doi.org/10.1111/epi.13706

Citation piece[edit | edit source]

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=High_phospho-Stathmin_(Serine38)_expression_identifies_aggressive_endometrial_cancer_and_suggests_an_association_with_PI3K_inhibition&oldid=5952"